天体细胞mGluR5依赖的过活性促进了粉样β病理和认知障碍
Tianqi Yang1,2,3, Dianjun Zhang1,2,3, Haiwei Huang1
1Department of General Intensive Care Unit of the Second Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Brain : a journal of neurology
|May 16, 2025
概括
星球细胞中升高的甲基氨酸受体5 (mGluR5) 驱动阿尔茨海默氏病的进展,因而导致过活. 针对天体细胞mGluR5提供了早期阿尔茨海默病的潜在治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 星细胞功能障碍是阿尔茨海默病 (AD) 发病的一个关键因素.
- 甲基增生谷氨酸受体5 (mGluR5) 与突触功能有关,在AD星球细胞中升高.
- 天体细胞mGluR5在阿尔茨海默病的发病过程中的确切作用尚不清楚.
研究的目的:
- 为了调查星细胞mGluR5对阿尔茨海默氏症病原发生的贡献.
- 探索星球细胞mGluR5表达和AD进展之间的相关性.
- 为了确定在早期的AD中准天体细胞mGluR5的治疗潜力.
主要方法:
- 在人类和小鼠AD大脑中量化星细胞mGluR5表达.
- 在AD小鼠模型的CA1区域中操纵天体细胞mGluR5水平.
- 在对mGluR5调制的反应中评估Aβ病理和认知功能.
- 对天体细胞活性和Aβ吸收/降解的分析.
主要成果:
- 天体细胞mGluR5表达在AD大脑中升高,与疾病进展相关.
- 星球细胞mGluR5的上调加速了AD病理和认知衰退,而下调则挽救了这些缺陷.
- mGluR5激活诱导了天体细胞过活,损害了Aβ清除.
- 减轻天体细胞过活性改善了在临床前阶段的AD病理和认知缺陷.
结论:
- 星系细胞mGluR5在阿尔茨海默氏症早期病变发生过程中起着至关重要的作用.
- 调节天体细胞mGluR5及其下游信号提供了一个有前途的治疗点AD.
- 准天体细胞mGluR5可能为预症状阿尔茨海默病提供一种新的诊断和治疗方法.
更多相关视频
06:43A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.1K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
相关概念视频
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
03:03Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K